Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells $2,304,963.12 in Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CEO Chad Robins sold 124,998 shares of the business's stock in a transaction dated Monday, February 2nd. The stock was sold at an...